RxDoctor Payments Data

Mark Lambrechts, MD

Orthopaedic Surgery of the Spine · Saint Louis, MONPI 1477904472

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Kuros Biosciences USA, Inc at 59.6% of the total. 2025 is the largest year on record at $19,374, 5.0 times the $3,890 reported in 2019.

$36,599in general payments, 2019–2025

Across 132 payments — averaging $277.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kuros Biosciences USA, Inc$22K
  • Elite Orthopedics, LLC$4K
  • Alphatec Spine, Inc$3K
  • Medical Device Business Services, Inc.$1K
  • Medtronic$1K
  • Arthrex$1K
  • plus $4K from 16 others

What the payments were for

  • Consulting fees$9,10025%
  • Grants$3371%
  • Travel & lodging$16,30645%
  • Food & beverage$8,59923%
  • Education$2,2406%
  • Entertainment$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,599 in reported general payments places this provider in the 65th percentile of 53 orthopaedic surgery of the spine providers in Missouri.

See all orthopaedic surgery of the spine providers in Missouri

Medicare billing

Part B allowed, 2024
$194,792
Medicare patients
180
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin80$765
Pregabalin54$639
Mupirocin74$571
Oxycodone Hcl78$563
Cyclobenzaprine Hcl48$329
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$277
Methylprednisolone25$168
Tramadol Hcl27$96
Meloxicam29$54

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →